Dan Edelstein
Company: Haystack Oncology
Job title: Chief Executive Officer
Seminars:
Panel Discussion: ctDNA Analysis has the Potential to Provide High-Definition Insights in Drug Development 6:15 pm
Stratify patients for trials Identify therapy response and resistance Quantifiably track variants Assess treatment outcome earlyRead more
day: Quest Diagnostics Engager